Nature biotechnology

• Latest
• Best
• Search…

• Nature biotechnology · May 2007

  Editorial

  Probity gone nuts.

  The thinking behind the US Food and Drug Administration's (FDA) draft guidance on financial conflicts of interest for outside experts is deeply flawed.

  read on… or not…

• Nature biotechnology · Apr 2007

  UK parses merits of value-based drug pricing.

  no abstract available

  expand abstract… or not…

• Nature biotechnology · Mar 2007

  Public sector seeks to bridge 'valley of death'.

  no abstract available

  read on… or not…

• Nature biotechnology · Mar 2007

  Comment Letter

  Two views of the emperor's new clones.

  no abstract available

  explore further… or just mark as read…

• Nature biotechnology · Mar 2007

  US aims to tighten rules on direct-to-consumer drug ads.

  no abstract available

  keep going… or not…